BioSpace News Archive

Business

BioGENEius Challenge Announces 2019 Mentor of the Year Awardee

The Biotechnology Institute announced the winner of the Mentor of the Year Award, who will be recognized next week at the 2019 BIO International Convention in Philadelphia.

June 1, 2019
·
3 min read
Drug Development

Moderna Announces Presentation of Interim Data from Phase 1 Study of mRNA Personalized Cancer Vaccine at 2019 ASCO Annual Meeting

Moderna, Inc. announced interim data from an ongoing Phase 1 clinical study in patients with both resected (adjuvant) and unresected (advanced) solid tumors.

June 1, 2019
·
10 min read
Drug Development

Five Prime Therapeutics Presents Monotherapy Data From the Phase 1a/1b Trial of FPA150 in Patients With Advanced Solid Tumors at the 2019 ASCO Annual Meeting

Five Prime Therapeutics, Inc. presented monotherapy data from the dose escalation portion of the Phase 1a/1b clinical trial of FPA150 in patients with advanced solid tumors.

June 1, 2019
·
5 min read
Job Trends

Magellan Health Opens a Toll-Free Crisis Line to Provide Free Counseling and Referral Services to Residents Impacted by the Shooting at the Virginia Beach Municipal Center

Counseling and resources available free-of-charge to local community

June 1, 2019
·
1 min read
BioMidwest

Caris Life Sciences Showcases Results from Novel Machine Learning Approach to Classify Cancer by Molecular Signatures

Caris Next Generation Profiling™ enables a proprietary algorithm to accurately classify tumors, demonstrating improvement in cancer diagnosis

June 1, 2019
·
4 min read
Policy

Veracyte Announces New Data Showing Potential of Afirma Genomic Test to Guide Targeted Treatment for Medullary Thyroid Cancer Concurrent with Diagnosis

Veracyte, Inc. announced new data demonstrating the potential for its Afirma® Xpression Atlas (XA) genomic test to guide targeted treatment selection for patients with a rare but aggressive form of thyroid cancer concurrent with diagnosis by the company’s Afirma Genomic Sequencing Classifier (GSC).

June 1, 2019
·
6 min read
Drug Development

IMV Inc. Presents New Positive Data from Phase 2 Monotherapy Arm of Its Decide1 Trial in Advanced Ovarian Cancer and Continued Duration of Clinical Benefits to Patients with Progression Free Survival

IMV Inc. announced that investigators shared new positive data for its DeCidE1 clinical trial at the 2019 American Society for Clinical Oncology Annual Meeting.

June 1, 2019
·
7 min read
Drug Development

Rakuten Medical Releases Phase 2a Study Data during ASCO Annual Meeting Highlighting Positive Safety Profile and Clinically Meaningful Anti-tumor Activity

Rakuten Medical announces positive data results from its Phase 2a study, evaluating the safety and anti-tumor activity of RM-1929 PIT in patients with locoregional, recurrent head and neck squamous cell carcinoma.

June 1, 2019
·
6 min read
Drug Development

Positive results of lurbinectedin Phase II trial (PharmaMar) for the treatment of relapsed small cell lung cancer are presented at ASCO

The results of PharmaMar’s (MSE: PHM) Phase II study with lurbinectedin as a single agent for the treatment of relapsed small cell lung cancer were presented to the American Society of Clinical Oncology (ASCO) conference, which is currently being held in Chicago.

June 1, 2019
·
5 min read
Drug Development

Kite Announces End of Phase 1 ZUMA-3 Results for KTE-X19 in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia

Kite, a Gilead Company, announced results from the completed Phase 1 of the ZUMA-3 study evaluating KTE-X19, an investigational CD19 chimeric antigen receptor T cell therapy.

June 1, 2019
·
6 min read